Entering text into the input field will update the search result below

Meridian Bioscience: Good Stock, But Margin Of Safety Required

Apr. 09, 2021 4:02 PM ETMeridian Bioscience, Inc. (VIVO)4 Comments
Libertus Research profile picture
Libertus Research


  • Meridian Bioscience benefited from a windfall due to the Covid-19 pandemic, resulting in the growth of its Life Science segment.
  • There will be a market for Covid testing in the post-Covid world, but the eventual market size of Covid testing remains uncertain.
  • Its Diagnostic segment is the key to watch. We need more evidence of success.
  • Hence, while we believe that this small cap has potential to be a multibagger for the long term, we require a margin of safety to mitigate the risks.

Scientists wearing full protective suit working in the laboratory
Photo by sanjeri/E+ via Getty Images

Investment Thesis

Meridian Bioscience (NASDAQ:VIVO) is a fast-growing company in the medical device industry. It has demonstrated a strong profitability record of approximately 60% gross profit margin and 20% EBIT margin, achieving ROE of between 12 to

This article was written by

Libertus Research profile picture
We are a team of working professionals who are building our portfolio of investments for long term capital appreciation on the side. Inspired by Christopher Mayer's 100 Baggers and Thomas Phelps' 100 to 1 in the Stock Market, we hunt for small cap stocks with the potential to return 100X.If you like what you read and wish to receive notifications for new publications, then click the "Follow" button in our profile. Our articles are meant to document our own decision-making process for our investments, and to battle-test our ideas with the Seeking Alpha community. In particular, we have always found constructive discussion in the comment section useful for our investment analysis - keep your feedback coming!Please do not take our articles as financial advice in any form and do your own due diligence when making financial/ investment decisions.Thank you for reading and good luck!

Analyst’s Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.